Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

OPINIONS

 oppenheimer-maintains-outperform-on-us-bancorp-lowers-price-target-to-54

Oppenheimer analyst Chris Kotowski maintains U.S. Bancorp (NYSE:USB) with a Outperform and lowers the price target from $55 ...

 equifax-reports-weak-sales-joins-synovus-financial-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures gaining over 50 points on Thursday.

 oppenheimer-reiterates-outperform-on-transcat-raises-price-target-to-125

Oppenheimer analyst Martin Yang reiterates Transcat (NASDAQ:TRNS) with a Outperform and raises the price target from $120 to...

 oppenheimer-maintains-perform-on-sage-therapeutics-lowers-price-target-to-17

Oppenheimer analyst Jay Olson maintains Sage Therapeutics (NASDAQ:SAGE) with a Perform and lowers the price target from $25 ...

 dr-horton-says-closed-homes-in-q3-will-be-23500-24000-sees-q3-gross-margin-of-23-235-expects-q3-revenue-of-95b-97b-vs-997b-est

- Conf Call

 wells-fargo-maintains-overweight-on-rhythm-pharmaceuticals-lowers-price-target-to-52

Wells Fargo analyst Derek Archila maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Overweight and lowers the price targ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist